Brook Preloader

Vincent Hennemand

Before being COO/CBO at Intergalactic Therapeutics, Vincent was SVP of Strategy, Corporate & Business Development at Akili, who was founded on the belief that effective medicine for serious illnesses could also be captivating and enjoyable to use, thereby the company has created digital neurological treatments engineered to directly improve cognitive deficits.

  • Intergalactic Therapeutics, COO/ CBO
  • Akili, SVP Strategy, Finance, Corporate and Business Development
  • Principal at Sanofi‚Äôs corporate R&D venture group, Sunrise
  • Chief of Staff to the President of Global R&D and the General Secretary for the Corporate
  • Scientific Advisory Committee (SDSAC) at Sanofi
  • Msc in Engingeering from Ecole Nationale Superieure Arts et Metiers in France
  • Msc in Bioengineering from Georgia Tech
  • MBA from MIT
  • Recipient of Martin Trust Center scholarship as Healthcare Sector Practice Leader for the Institute